Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-26 @ 2:41 AM
Study NCT ID:
NCT04916002
Status:
TERMINATED
Last Update Posted:
2025-12-05
First Post:
2021-06-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-01
First Submit QC Date:
None
Study First Post Date:
2021-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-10-30
Results First Submit QC Date:
None
Results First Post Date:
2025-12-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED